Innovex International, Inc. (INVX) Financial Statements
Innovex International, Inc. (INVX) reported trailing twelve-month revenue of $997.5M (up 15.0% year on year) and net income of $61.6M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $124.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
INVXInnovex International, Inc.Follow INVX — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- 33.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.57 | 0.60 | 0.73 | 0.87 | 0.93 | 0.84 | 0.54 | 0.46 | 0.34 | 0.38 | 0.33 | 0.29 | 0.47 | 0.56 | 0.66 | 0.98 | 1.00 | |
| Gross profit | 0.24 | 0.24 | 0.28 | 0.36 | 0.42 | 0.39 | 0.21 | 0.13 | 0.04 | 0.08 | 0.06 | -0.02 | 0.16 | 0.20 | 0.23 | 0.30 | 0.32 | |
| Research & development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.00 | 0.01 | — | |
| Operating income | 0.14 | 0.13 | 0.16 | 0.22 | 0.28 | 0.25 | 0.11 | -0.07 | -0.12 | 0.00 | -0.06 | -0.13 | 0.08 | 0.10 | 0.05 | 0.13 | 0.10 | |
| Pre-tax income | 0.14 | 0.13 | 0.16 | 0.22 | 0.28 | 0.25 | 0.12 | -0.07 | -0.11 | 0.01 | -0.06 | -0.13 | 0.07 | 0.09 | 0.14 | 0.13 | 0.10 | |
| Income tax | 0.04 | 0.03 | 0.04 | 0.05 | 0.07 | 0.06 | 0.02 | 0.03 | -0.02 | 0.01 | -0.03 | 0.00 | 0.01 | 0.02 | 0.00 | 0.05 | 0.04 | |
| Net income | 0.10 | 0.10 | 0.12 | 0.17 | 0.21 | 0.19 | 0.09 | -0.10 | -0.10 | 0.00 | -0.03 | -0.13 | 0.06 | 0.07 | 0.14 | 0.08 | 0.06 | |
| Diluted EPS ($) | 2.55 | 2.36 | 2.94 | 4.16 | 5.19 | 4.98 | 2.47 | -2.69 | -2.58 | 0.05 | -0.87 | -3.63 | 2.01 | 2.29 | 2.77 | 1.20 | 0.89 | |
| Diluted shares (bn) | 0.040 | 0.040 | 0.041 | 0.041 | 0.040 | 0.039 | 0.038 | 0.037 | 0.037 | 0.036 | 0.035 | 0.035 | 0.031 | 0.032 | 0.051 | 0.069 | — |
USD billions · SEC XBRL
Innovex International, Inc. — questions
- What is Innovex International, Inc.'s revenue?
- $997.5M over the twelve months to 2026-06-30, up 15.0% year on year, from its 10-Q and 10-K filings.
- What is Innovex International, Inc.'s net income?
- $61.6M over the twelve months to 2026-06-30.
- What is Innovex International, Inc.'s free cash flow?
- $124.2M over the twelve months to 2026-06-30.
- What are Innovex International, Inc.'s diluted earnings per share?
- $0.89 over the twelve months to 2026-06-30.
Every figure on this page comes from Innovex International, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.